Press release article from our research archive:

FDA APPROVES PMA FOR INTEGRA LIFESCIENCES CORPORATION'S ARTIFICIAL SKIN: FIRST OF A NEW CLASS OF TISSUE REGENERATION PRODUCTS

PLAINSBORO, N.J., March 4 /PRNewswire/ Integra LifeSciences Corporation (Nasdaq NNM: IART) announced today that it has received notification from the U.S. Food and Drug Administration (FDA) that its Premarket Approval Application (PMA) seeking permission to market the Company's INTEGRA(TM) Artificial Skin, Dermal Regeneration Template(TM) device is approved. The INTEGRA Artificial Skin product is indicated for the treatment of patients with life-threatening full-thickness or deep partial-thickness burns where conventional autograft is not available or not desirable due to the physiological condition of the patient. The Company believes that INTEGRA Artificial Skin is the ...

Related newspaper, magazine, and journal articles:

See all results. Or, try our Advanced Search.

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 60 million articles! Access over 3,500 publications with a FREE trial!